Considering only the bone metastases, this translates to a higher metastatic burden caused by the ZEB1-expressing cells, as indicated by a significantly higher metastatic index (that is, the ratio of the average bioluminescent radiance of the metastatic organ over that of the corresponding primary tumor) (Fig. 7b). The gene discussed is ZEB1; the disease is neoplasm.